Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Singhal

Showing results (631-640 of 791) with videos related to

Pageof 80
Sort By:
Stem Cells (Dayton, Ohio)|August 1, 1995
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescueR Powles, N Raje, D Cunningham, et al.
Oncotarget|March 9, 2022
Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
PCSK9 and High-Fat Diet Synergistically Induce Neurovascular Dysfunction and NeuroinflammationMengqi Zhang, Anudari Letian, Gregory A Mohl, et al.
Bone Marrow Transplantation|August 11, 2001
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteriaB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Cancer|August 7, 2001
Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myelomaB Sirohi, R Powles, S Kulkarni, et al.
Biochemical and Biophysical Research Communications|November 10, 2000
Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucilU Pandya, S K Srivastava, S S Singhal, et al.
Bone Marrow Transplantation|March 14, 2000
The role of autologous transplantation in patients with multiple myeloma aged 65 years and overB Sirohi, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|November 20, 2002
Reassessing the definition of myeloid engraftment after autotransplantation: it is not necessary to see 0.5 x 10(9)/l neutrophils on 3 consecutive days to define myeloid recoveryM Y Ali, Y Oyama, J Monreal, et al.
Bone Marrow Transplantation|January 27, 2004
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?A Verma, J Pedicano, S Trifilio, et al.
European Journal of Biochemistry|September 15, 1994
Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic propertiesP Zimniak, B Nanduri, S Pikuła, et al.
Pageof 80

Showing results (631-640 of 791) with videos related to

Sort By:
Pageof 80
Stem Cells (Dayton, Ohio)|August 1, 1995
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescueR Powles, N Raje, D Cunningham, et al.
Oncotarget|March 9, 2022
Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
PCSK9 and High-Fat Diet Synergistically Induce Neurovascular Dysfunction and NeuroinflammationMengqi Zhang, Anudari Letian, Gregory A Mohl, et al.
Bone Marrow Transplantation|August 11, 2001
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteriaB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Cancer|August 7, 2001
Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myelomaB Sirohi, R Powles, S Kulkarni, et al.
Biochemical and Biophysical Research Communications|November 10, 2000
Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucilU Pandya, S K Srivastava, S S Singhal, et al.
Bone Marrow Transplantation|March 14, 2000
The role of autologous transplantation in patients with multiple myeloma aged 65 years and overB Sirohi, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|November 20, 2002
Reassessing the definition of myeloid engraftment after autotransplantation: it is not necessary to see 0.5 x 10(9)/l neutrophils on 3 consecutive days to define myeloid recoveryM Y Ali, Y Oyama, J Monreal, et al.
Bone Marrow Transplantation|January 27, 2004
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?A Verma, J Pedicano, S Trifilio, et al.
European Journal of Biochemistry|September 15, 1994
Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic propertiesP Zimniak, B Nanduri, S Pikuła, et al.
Pageof 80